“…Egr-1 is activated rapidly in response to many different factors, including neural activity and neurotransmission, growth factors, cytokines, pharmacological agents, stimulation, stress, and DNA damage, among others, indicating that Egr-1 is involved in a multitude of physiological processes and regulates many different synapse-associated genes (Gashler and Sukhatme, 1995 ; Beckmann and Wilce, 1997 ; O’Donovan et al, 1999 ; Clayton, 2000 ; James et al, 2005 ; Pagel and Deindl, 2011 ). In addition to agrin regulation as described in this study, Egr-1 also influences the expression and regulation of the plasticity related Arc gene, as well as SNARE, synapsin II, serpine I, galectin-3 binding protein, integrin associated protein (IAP), cystatin c, PSD95, Shank3, neuronal specific septin 3, s100B, phospholipase C, protein kinase C, BACE1 and drebrin among several others (James et al, 2005 ; Li et al, 2005 ; Baumgärtel et al, 2009 ; Qin et al, 2016 ; Cho et al, 2017 ). Thus, Egr-1 may have direct targets in addition to, or other than, agrin, which may contribute to or cause the noted changes of Egr-1−/− mice compared with WT, as seen in this study.…”